Ольга Леонидовна Сайбель
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ольга Леонидовна Сайбель has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
- Andrey Ivanovich Radimich
Всероссийский научно-исследовательский институт лекарственных и ароматических растений
6 shared publications - Тамара Дарижаповна Даргаева
Всероссийский научно-исследовательский институт лекарственных и ароматических растений
4 shared publications - Екатерина Владимировна Ферубко
Всероссийский научно-исследовательский институт лекарственных и ароматических растений
3 shared publications - Ирина Александровна Лупанова
All-Russian Research Institute of Medicinal and Aromatic Plants; 7 Grina Street, Moscow, 117216, Russian Federation
3 shared publications - E. N. Kurmanova
Всероссийский научно-исследовательский институт лекарственных и ароматических растений
2 shared publications - Evgeny Sergeyevich Melnikov
Department of Pharmaceutical and Toxicological Chemistry, Sechenov First Moscow State Medical University (Sechenov University), Moscow 119991, Russia
2 shared publications
Latest Publications
- Open Access
- 7 September 2026
- Published by Altai State University in Chemistry of plant raw material
- No. 3
PHENOLIC COMPOUNDS OF GLEBIONIS CORONARIA HERB EXTRACT AND ITS ANTIOXIDANT ACTIVITY
Recent studies have shown the potential of using plant phenolic compounds as effective antioxidants to reduce the possible risks of developing various pathologies and to maintain active longevity in people. The source of such agents can be the Glebionis coronaria L. Cass. ex Spach. (Chrysanthemum coronarium L.). The aim of our study was to examine the qualitative composition of phenolic compounds and the antioxidant properties of the Glebionis coronaria herb extract to assess the prospects for its further study as a substance for obtaining therapeutic and prophylactic agents. The composition of phenolic compounds was studied using HPLC-MS. The antioxidant activity was assessed using model systems simulating the reactions of reactive oxygen species (ROS) and lipid peroxidation (LPO) formation. As a result of the study, flavonoids (luteolin, cynaroside, luteolin-glucuronide, luteolin-malonylglucuronide, rutin and quercetin-glucorhamnoside), caffeoylquinic acids (chlorogenic acid and its isomers, dicaffeoylquinic acid and its isomer, succinyl-dicaffeoylquinic acid and its isomer, disuccinyl-dicaffeoylquinic acid), amide derivatives of caffeic acid (caffeoyl-leucine, caffeoyl-phenylalanine and their isomers), organic acids (quinic and malonic acids) were identified in the extract. The extract of the Glebionis coronaria herb decreased the generation of ROS by 17.8% and decreased the rate of lipid peroxidation by 15.9%, thereby demonstrating antioxidant properties, presumably due to the flavonoids and caffeoylquinic acids contained in it. Further research of Glebionis coronaria herbs in the direction of developing therapeutic and prophylactic agents is of interest.
- 7 September 2026
- Published by Altai State University in Chemistry of plant raw material
- No. 3
Open AccessPHENOLIC COMPOUNDS OF GLEBIONIS CORONARIA HERB EXTRACT AND ITS ANTIOXIDANT ACTIVITY
Recent studies have shown the potential of using plant phenolic compounds as effective antioxidants to reduce the possible risks of developing various pathologies and to maintain active longevity in people. The source of such agents can be the Glebionis coronaria L. Cass. ex Spach. (Chrysanthemum coronarium L.). The aim of our study was to examine the qualitative composition of phenolic compounds and the antioxidant properties of the Glebionis coronaria herb extract to assess the prospects for its further study as a substance for obtaining therapeutic and prophylactic agents. The composition of phenolic compounds was studied using HPLC-MS. The antioxidant activity was assessed using model systems simulating the reactions of reactive oxygen species (ROS) and lipid peroxidation (LPO) formation. As a result of the study, flavonoids (luteolin, cynaroside, luteolin-glucuronide, luteolin-malonylglucuronide, rutin and quercetin-glucorhamnoside), caffeoylquinic acids (chlorogenic acid and its isomers, dicaffeoylquinic acid and its isomer, succinyl-dicaffeoylquinic acid and its isomer, disuccinyl-dicaffeoylquinic acid), amide derivatives of caffeic acid (caffeoyl-leucine, caffeoyl-phenylalanine and their isomers), organic acids (quinic and malonic acids) were identified in the extract. The extract of the Glebionis coronaria herb decreased the generation of ROS by 17.8% and decreased the rate of lipid peroxidation by 15.9%, thereby demonstrating antioxidant properties, presumably due to the flavonoids and caffeoylquinic acids contained in it. Further research of Glebionis coronaria herbs in the direction of developing therapeutic and prophylactic agents is of interest.
- Open Access
- 24 November 2025
- Published by Belgorod National Research University in Research Results in Pharmacology
- Vol. 11 (4) , 131-139
Нейропротективная активность экстракта плодов софоры японской при ишемии-реперфузии головного мозга
Введение. В последнее время возрос интерес к изучению флавоноидов, обладающих нейропротекторной активностью. Плоды софоры японской являются источником таких флавоноидов. Цель исследования: определение нейропротективного влияния экстракта плодов софоры японской (ЭПС) при ишемии-реперфузии головного мозга у крыс. Материалы и методы. Модель ишемии-реперфузии воспроизводили у крыс путем окклюзии общих сонных артерий с гипотензией. Влияние ЭПС на неврологический статус животных и их поведение определяли с помощью неврологических и этологических тестов – открытое поле (ОП) и крестообразный приподнятый лабиринт (КПЛ). Влияние ЭПС на морфофункциональное состояние головного мозга крыс при ишемии-реперфузии определяли патоморфологическим методом. Результаты. Неврологический дефицит у групп животных, получавших ЭПС был меньше контрольных значений в 3 раза, показатели двигательной активности в тесте ОП были выше в 2 раза; уровень тревожности у крыс в тесте КПЛ был меньше: количество выходов в открытые рукава лабиринта и время, проведенное в них, были больше в 3,8 раз и 10 раз соответственно по сравнению с контролем. У крыс опытных групп доли регрессивных форм нейронов в коре и гиппокампе были меньше по сравнению с контролем, установленные при морфологическом исследовании. Доминирующим компонентом является софорафлавонолозид. Заключение. ЭПС оказывает нейропротективное влияние при ишемии-реперфузии головного мозга у крыс: уменьшает неврологический дефицит, ограничивает развитие поведенческих нарушений, предотвращает повреждение нейронов в коре больших полушарий и гиппокампе. Нейропротективное действие ЭПС предположительно может быть обусловлено активностью гликозидов кемпферола, доминирующим среди которых является софорафлавонолозид.
- 24 November 2025
- Published by Belgorod National Research University in Research Results in Pharmacology
- Vol. 11 (4) , 131-139
Open AccessНейропротективная активность экстракта плодов софоры японской при ишемии-реперфузии головного мозга
Введение. В последнее время возрос интерес к изучению флавоноидов, обладающих нейропротекторной активностью. Плоды софоры японской являются источником таких флавоноидов. Цель исследования: определение нейропротективного влияния экстракта плодов софоры японской (ЭПС) при ишемии-реперфузии головного мозга у крыс. Материалы и методы. Модель ишемии-реперфузии воспроизводили у крыс путем окклюзии общих сонных артерий с гипотензией. Влияние ЭПС на неврологический статус животных и их поведение определяли с помощью неврологических и этологических тестов – открытое поле (ОП) и крестообразный приподнятый лабиринт (КПЛ). Влияние ЭПС на морфофункциональное состояние головного мозга крыс при ишемии-реперфузии определяли патоморфологическим методом. Результаты. Неврологический дефицит у групп животных, получавших ЭПС был меньше контрольных значений в 3 раза, показатели двигательной активности в тесте ОП были выше в 2 раза; уровень тревожности у крыс в тесте КПЛ был меньше: количество выходов в открытые рукава лабиринта и время, проведенное в них, были больше в 3,8 раз и 10 раз соответственно по сравнению с контролем. У крыс опытных групп доли регрессивных форм нейронов в коре и гиппокампе были меньше по сравнению с контролем, установленные при морфологическом исследовании. Доминирующим компонентом является софорафлавонолозид. Заключение. ЭПС оказывает нейропротективное влияние при ишемии-реперфузии головного мозга у крыс: уменьшает неврологический дефицит, ограничивает развитие поведенческих нарушений, предотвращает повреждение нейронов в коре больших полушарий и гиппокампе. Нейропротективное действие ЭПС предположительно может быть обусловлено активностью гликозидов кемпферола, доминирующим среди которых является софорафлавонолозид.
- 27 December 2024
- Published by Folium Publishing Company in Химико-фармацевтический журнал
- Vol. 58 (12) , 29-34
Определение флавоноидного состава экстракта из плодов софоры японской и оценка его церебропротекторной активности
Целью настоящего исследования явилось изучение состава и содержания флавоноидов экстракта плодов софоры японской, а также оценка его церебропротекторной и антиоксидантной активности. В результате проведенного исследования методом ВЭЖХ-УФ-МС в экстракте идентифицированы гликозиды кемпферола, кверцетина, генистеина и изорамнетина. Химический анализ показал, что содержание суммы флавоноидов составляет 50,82 ± 1,02 %. На модели ишемии головного мозга на белых крысах установлено, что экстракт в максимальной экспериментальной дозе 200 мг/кг оказывает церебропротекторное действие: выживаемость составила 67 % при контрольном значении 20 %, а неврологический дефицит был меньше на 26,5 % (p ≤ 0,05) по сравнению с контролем. С помощью ДФПГ-теста показано, что экстракт проявляет выраженную антиоксидантную активность: показатель IC50 составил 206,97 ± 22,5 мкг/мл.
- 27 December 2024
- Published by Folium Publishing Company in Химико-фармацевтический журнал
- Vol. 58 (12) , 29-34
Определение флавоноидного состава экстракта из плодов софоры японской и оценка его церебропротекторной активности
Целью настоящего исследования явилось изучение состава и содержания флавоноидов экстракта плодов софоры японской, а также оценка его церебропротекторной и антиоксидантной активности. В результате проведенного исследования методом ВЭЖХ-УФ-МС в экстракте идентифицированы гликозиды кемпферола, кверцетина, генистеина и изорамнетина. Химический анализ показал, что содержание суммы флавоноидов составляет 50,82 ± 1,02 %. На модели ишемии головного мозга на белых крысах установлено, что экстракт в максимальной экспериментальной дозе 200 мг/кг оказывает церебропротекторное действие: выживаемость составила 67 % при контрольном значении 20 %, а неврологический дефицит был меньше на 26,5 % (p ≤ 0,05) по сравнению с контролем. С помощью ДФПГ-теста показано, что экстракт проявляет выраженную антиоксидантную активность: показатель IC50 составил 206,97 ± 22,5 мкг/мл.
- Open Access
- 9 August 2024
- Published by Center of Pharmaceutical Analytics Ltd in Drug development & registration
Identification of luteolin-7-glucoside metabolites after oral administration and development of a method for their quantitative analysis
Introduction. The development and registration of antiviral drugs is an urgent task. Flavonoids, in particular, luteolin-7-glycoside (cinaroside, luteolin-7-O-glycoside) demonstrate high broad-spectrum antiviral activity in vitro, and the industrial regulations for the production of luteolin-7-glycoside from the leaves of holly willow have already been developed at the VILAR. One of the problems with the introduction of flavonoids into medical practice is their low bioavailability and intensive biotransformation. Existing publications provide contradictory data on the pharmacokinetics of luteolin-7-glycoside, and therefore our own research was conducted.Aim. To develop a methodology for the quantitative analysis of luteolin-7-glycoside and its metabolites in blood plasma and to test it on laboratory animals.Materials and methods. Animal experiments were carried out in accordance with the requirements of the "Guidelines for conducting preclinical studies of medicines". To develop a method of analysis and further clarify the time intervals of blood sampling, time points were analyzed: 30, 60 minutes, 2, 4, 8, 24 hours after administration of the test substance. Tubes with citrate blood of laboratory animals were centrifuged at 2000 rpm for 10 minutes. The plasma was placed in an Eppendorf-type test tube, frozen and stored at –20 °C until chromatographic analysis was performed. Blood plasma sample preparation was carried out by precipitation with methyl alcohol, the supernatant was chromatographically separated on a column Luna® 5 µm C18 column 100 Å 250 × 4.6 mm in a gradient mode in a water-acetonitrile system and a modifier – 0.2 % formic acid. The metabolites were identified by high-performance liquid chromatography with mass spectrometric detection. To do this, the spectral characteristics of the peaks that appeared on the chromatograms of blood plasma samples after oral administration of luteolin-7-glycoside were interpreted. The concentration of the analyzed substances was assessed by the internal standard method, which was rutin. To determine the concentration of luteolin, a standardized luteolin substance was used as a standard sample, the concentration of the remaining metabolites was estimated in terms of luteolin.Results and discussion. It was found that after oral administration of luteolin-7-glycoside in starch paste to laboratory animals, native luteolin-7-glycoside was not detected in blood plasma. The main metabolites were luteolin-diglucuronide and luteolin-glucuronide, their maximum plasma concentrations are about three times higher than luteolin and methyllyuteolin-diglucuronide. The results are compared with data from other studies.Conclusion. The absence of native luteolin-7-glycoside in blood plasma after oral administration makes it necessary to seriously reconsider the relevance of the conclusions obtained during studies of its activity in vitro. However, in the presence of antiviral activity in vivo, there is an urgent need for further research to establish the real mechanisms of action of this medicinal substance.
- 9 August 2024
- Published by Center of Pharmaceutical Analytics Ltd in Drug development & registration
Open AccessIdentification of luteolin-7-glucoside metabolites after oral administration and development of a method for their quantitative analysis
Introduction. The development and registration of antiviral drugs is an urgent task. Flavonoids, in particular, luteolin-7-glycoside (cinaroside, luteolin-7-O-glycoside) demonstrate high broad-spectrum antiviral activity in vitro, and the industrial regulations for the production of luteolin-7-glycoside from the leaves of holly willow have already been developed at the VILAR. One of the problems with the introduction of flavonoids into medical practice is their low bioavailability and intensive biotransformation. Existing publications provide contradictory data on the pharmacokinetics of luteolin-7-glycoside, and therefore our own research was conducted.Aim. To develop a methodology for the quantitative analysis of luteolin-7-glycoside and its metabolites in blood plasma and to test it on laboratory animals.Materials and methods. Animal experiments were carried out in accordance with the requirements of the "Guidelines for conducting preclinical studies of medicines". To develop a method of analysis and further clarify the time intervals of blood sampling, time points were analyzed: 30, 60 minutes, 2, 4, 8, 24 hours after administration of the test substance. Tubes with citrate blood of laboratory animals were centrifuged at 2000 rpm for 10 minutes. The plasma was placed in an Eppendorf-type test tube, frozen and stored at –20 °C until chromatographic analysis was performed. Blood plasma sample preparation was carried out by precipitation with methyl alcohol, the supernatant was chromatographically separated on a column Luna® 5 µm C18 column 100 Å 250 × 4.6 mm in a gradient mode in a water-acetonitrile system and a modifier – 0.2 % formic acid. The metabolites were identified by high-performance liquid chromatography with mass spectrometric detection. To do this, the spectral characteristics of the peaks that appeared on the chromatograms of blood plasma samples after oral administration of luteolin-7-glycoside were interpreted. The concentration of the analyzed substances was assessed by the internal standard method, which was rutin. To determine the concentration of luteolin, a standardized luteolin substance was used as a standard sample, the concentration of the remaining metabolites was estimated in terms of luteolin.Results and discussion. It was found that after oral administration of luteolin-7-glycoside in starch paste to laboratory animals, native luteolin-7-glycoside was not detected in blood plasma. The main metabolites were luteolin-diglucuronide and luteolin-glucuronide, their maximum plasma concentrations are about three times higher than luteolin and methyllyuteolin-diglucuronide. The results are compared with data from other studies.Conclusion. The absence of native luteolin-7-glycoside in blood plasma after oral administration makes it necessary to seriously reconsider the relevance of the conclusions obtained during studies of its activity in vitro. However, in the presence of antiviral activity in vivo, there is an urgent need for further research to establish the real mechanisms of action of this medicinal substance.
- Open Access
- 19 August 2022
- Published by SCEEMP in Bulletin of the Scientific Centre for Expert Evaluation of Medicinal Products. Regulatory Research and Medicine Evaluation
- Vol. 12 (3) , 288-299
Quantification of Residual Organochlorine Pesticides in Medicinal Plant Raw Materials Containing Terpenoids
An important indicator of the safety of plant raw materials and herbal medicinal products is the content of residual pesticides. Its determination is particularly difficult in aromatic plants characterised by a diverse composition of terpenoids co-extracting with organochlorine pesticides and forming numerous degradation products that interfere with the analysis.The aim of the study was to develop and validate an analytical procedure for the quantification of organochlorine pesticides in plant raw materials containing terpenoids, compliant with the requirements of the State Pharmacopoeia of the Russian Federation.Materials and methods: the study analysed samples of morphologically different raw materials from 21 plant species containing terpenoids. The analysis was carried out by GLC-MS on a 450-GC gas chromatograph coupled to a 220-MS ion-trap mass spectrometer (Varian, USA) using a FactorFour VF-5ms quartz capillary column (30 m × 0.25 mm).Results: the authors developed the analytical procedure for organochlorine pesticides in medicinal plant raw materials containing terpenoids. Its specificity was confirmed by retention times and mass spectra for all the tested analytes. The recovery of pesticides was studied on model mixtures of a plant raw material and ranged from 70.04 to 99.27%. The authors established the linearity using a calibration curve for internal standard (4,4'-dibromodiphenyl) concentrations from 1.0 to 18.1 µg/mL. The procedure was linear across the entire studied range; the correlation coefficient equalled 0.999. The trueness and precision of the analytical procedure met the acceptance criteria.Conclusions: the analytical procedure has been put into use at the Testing Centre of VILAR. From 2018 to 2020, 63 samples of 21 types of medicinal plant raw materials were analysed and found to be corresponding to the safety requirements for the organochlorine pesticide content. Residual pesticides were detected in the medicinal plant raw materials in few sporadic cases.
- 19 August 2022
- Published by SCEEMP in Bulletin of the Scientific Centre for Expert Evaluation of Medicinal Products. Regulatory Research and Medicine Evaluation
- Vol. 12 (3) , 288-299
Open AccessQuantification of Residual Organochlorine Pesticides in Medicinal Plant Raw Materials Containing Terpenoids
An important indicator of the safety of plant raw materials and herbal medicinal products is the content of residual pesticides. Its determination is particularly difficult in aromatic plants characterised by a diverse composition of terpenoids co-extracting with organochlorine pesticides and forming numerous degradation products that interfere with the analysis.The aim of the study was to develop and validate an analytical procedure for the quantification of organochlorine pesticides in plant raw materials containing terpenoids, compliant with the requirements of the State Pharmacopoeia of the Russian Federation.Materials and methods: the study analysed samples of morphologically different raw materials from 21 plant species containing terpenoids. The analysis was carried out by GLC-MS on a 450-GC gas chromatograph coupled to a 220-MS ion-trap mass spectrometer (Varian, USA) using a FactorFour VF-5ms quartz capillary column (30 m × 0.25 mm).Results: the authors developed the analytical procedure for organochlorine pesticides in medicinal plant raw materials containing terpenoids. Its specificity was confirmed by retention times and mass spectra for all the tested analytes. The recovery of pesticides was studied on model mixtures of a plant raw material and ranged from 70.04 to 99.27%. The authors established the linearity using a calibration curve for internal standard (4,4'-dibromodiphenyl) concentrations from 1.0 to 18.1 µg/mL. The procedure was linear across the entire studied range; the correlation coefficient equalled 0.999. The trueness and precision of the analytical procedure met the acceptance criteria.Conclusions: the analytical procedure has been put into use at the Testing Centre of VILAR. From 2018 to 2020, 63 samples of 21 types of medicinal plant raw materials were analysed and found to be corresponding to the safety requirements for the organochlorine pesticide content. Residual pesticides were detected in the medicinal plant raw materials in few sporadic cases.
- Open Access
- 15 May 2022
- Published by Russian Gastroenterolgocial Society in Russian Journal of Gastroenterology, Hepatology, Coloproctology
- Vol. 32 (2) , 55-62
Antitoxic Effects of Chicory Herb Extract Fractions in Rats with Toxic Hepatitis
Aim. To evaluate the antitoxic activity of chicory herb extract fractions in rats with toxic hepatitis.Materials and methods. There were 64 male rats were divided into groups of 6 animals that received the whole chicory herb extract, its fractions, or the reference drug (RD) and 2 groups did not receive any drug. The Silimar substance (a dry purified extract obtained from the fruits of milk thistle [Silybum marianum]) was chosen as RD. Animals from one of the groups that did not receive the drug (control group) and the groups that received drugs were injected with CCl4 to simulate toxic liver damage. The last group of animals received neither drugs nor CCl4 (intact animals). The changes in the activity of biotransformation enzymes (cytochrome P450 [cytР450] and glutathione transferase [GT]) in hepatocytes and serum liver enzymes (AST, ALT and AP) were assessed.Results. There was a decrease in cytР450 and GT activity in the liver microsomes of control rats (having CCl4 hepatitis without treatment) compared with intact animals. These parameters were more in the animals that were administrated with chicory herb extract, its fractions, and RD than in control animals. The administration of the whole extract, aqueous fraction, and RD led to an increase in the activity of cytP450 and GT enzymes almost to the level of the same indicators in intact animals. Pronounced grown in the activity of serum liver enzymes (ALT, AST and AP) were found after CCl4 injection. Administration of common chicory herb fractions before toxic liver damage caused a decrease in the grown of the activity of these enzymes. The greatest inhibitory effect on the grown of the activity of these liver enzymes had RD, aqueous and butanolic fractions of chicory herb. Despite a significant decrease in hyperfermentemia found in groups of animals treated with fractions of chicory herb, AST, ALT and AP activities did not reach the level that was in the intact animal group.Conclusion. The aqueous and butanolic fractions of the chicory herb extract had the highest antitoxic activity in experimental animal toxic liver injury.
- 15 May 2022
- Published by Russian Gastroenterolgocial Society in Russian Journal of Gastroenterology, Hepatology, Coloproctology
- Vol. 32 (2) , 55-62
Open AccessAntitoxic Effects of Chicory Herb Extract Fractions in Rats with Toxic Hepatitis
Aim. To evaluate the antitoxic activity of chicory herb extract fractions in rats with toxic hepatitis.Materials and methods. There were 64 male rats were divided into groups of 6 animals that received the whole chicory herb extract, its fractions, or the reference drug (RD) and 2 groups did not receive any drug. The Silimar substance (a dry purified extract obtained from the fruits of milk thistle [Silybum marianum]) was chosen as RD. Animals from one of the groups that did not receive the drug (control group) and the groups that received drugs were injected with CCl4 to simulate toxic liver damage. The last group of animals received neither drugs nor CCl4 (intact animals). The changes in the activity of biotransformation enzymes (cytochrome P450 [cytР450] and glutathione transferase [GT]) in hepatocytes and serum liver enzymes (AST, ALT and AP) were assessed.Results. There was a decrease in cytР450 and GT activity in the liver microsomes of control rats (having CCl4 hepatitis without treatment) compared with intact animals. These parameters were more in the animals that were administrated with chicory herb extract, its fractions, and RD than in control animals. The administration of the whole extract, aqueous fraction, and RD led to an increase in the activity of cytP450 and GT enzymes almost to the level of the same indicators in intact animals. Pronounced grown in the activity of serum liver enzymes (ALT, AST and AP) were found after CCl4 injection. Administration of common chicory herb fractions before toxic liver damage caused a decrease in the grown of the activity of these enzymes. The greatest inhibitory effect on the grown of the activity of these liver enzymes had RD, aqueous and butanolic fractions of chicory herb. Despite a significant decrease in hyperfermentemia found in groups of animals treated with fractions of chicory herb, AST, ALT and AP activities did not reach the level that was in the intact animal group.Conclusion. The aqueous and butanolic fractions of the chicory herb extract had the highest antitoxic activity in experimental animal toxic liver injury.
- Open Access
- 25 November 2021
- Published by Center of Pharmaceutical Analytics Ltd in Drug development & registration
- Vol. 10 (4) , 36-45
Phenolic Compounds and Hepatoprotective Activity of Chicory Herb Extract
Introduction. Chicory (Cichorium intybus L.) is widely applied for liver disease treatment by traditional medicine of different countries; as well, it is the object for pharmacological research of hepatoprotective activity. In this regard, the method for obtaining dry extract of wild chicory herb (WCHE) is developed in the All-Russian Research Institute of Medicinal and Aromatic Plants.Aim. Aim of the research is determination of the qualitative composition of phenolic compounds, identification of the substances prevailing in WCHE and conducting pharmacological screening of the extract.Materials and methods. WCHE chemical composition has been explored with HPLC-MS/MS method; the main components were determined quantitatively with HPLC-UF method using single compounds that were isolated by us earlier and identified by NMR spectroscopy. WCHE pharmacological screening of hepatoprotective activity research was involving 50 male rats. Acute toxic hepatitis in animals was induced by a single subcutaneous injection of 50 % oily solution of tetrachloromethane (TCM) at a dosage of 0.4 ml per 100 g body weight. One hour before administration TCM, animals received WCHE at the doses of 100 or 500 mg/kg. 48 hours after TCM administration, the activity of serum enzymes alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphatase (ALP), as well as the content of total bilirubin were determined for preliminary establishment of pharmacological activity. Pathomorphological studies of rat liver were carried out using histological methods. The liver histological structure was inspected using liver sections stained with hematoxylin and eosin.Results and discussion. The component composition of WCHE is represented by oxycoumarins, hydroxycinnamic acids and flavonoids. The dominant phenolic compounds are esculetin, chicoriin, chicoric, chlorogenic and caftaric acids. It was found under acute experimental toxic hepatitis, that preliminary WCHE administration reduces the toxic TCM effect on liver cells. In animals treated with WCHE at doses both 100 mg/kg and 500 mg/kg body weight, it was observed decreases in ALT activity by 35 % and 45 %, AST by 15 % and 28 %, alkaline phosphatase by 15 % and 21 %; the content of total bilirubin by 20 % and 29 %, respectively, in comparison with similar indicators in the group of animals that were not treated with the extract. The histological study showed that WCHE administration to animals at the doses of 100 and 500 mg/kg reduces dystrophic changes in hepatocytes, this effect is more pronounced at the extract dosage of 500 mg/kg.Conclusion. Main WCHE components are oxycoumarins (esculetin, chicoriin), hydroxycinnamic acids (chicoric, chlorogenic and caftaric). According to the results of screening studies, it was established that WCHE in doses of 100 mg/kg and 500 mg/kg is a promising object for further pharmacological research.
- 25 November 2021
- Published by Center of Pharmaceutical Analytics Ltd in Drug development & registration
- Vol. 10 (4) , 36-45
Open AccessPhenolic Compounds and Hepatoprotective Activity of Chicory Herb Extract
Introduction. Chicory (Cichorium intybus L.) is widely applied for liver disease treatment by traditional medicine of different countries; as well, it is the object for pharmacological research of hepatoprotective activity. In this regard, the method for obtaining dry extract of wild chicory herb (WCHE) is developed in the All-Russian Research Institute of Medicinal and Aromatic Plants.Aim. Aim of the research is determination of the qualitative composition of phenolic compounds, identification of the substances prevailing in WCHE and conducting pharmacological screening of the extract.Materials and methods. WCHE chemical composition has been explored with HPLC-MS/MS method; the main components were determined quantitatively with HPLC-UF method using single compounds that were isolated by us earlier and identified by NMR spectroscopy. WCHE pharmacological screening of hepatoprotective activity research was involving 50 male rats. Acute toxic hepatitis in animals was induced by a single subcutaneous injection of 50 % oily solution of tetrachloromethane (TCM) at a dosage of 0.4 ml per 100 g body weight. One hour before administration TCM, animals received WCHE at the doses of 100 or 500 mg/kg. 48 hours after TCM administration, the activity of serum enzymes alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphatase (ALP), as well as the content of total bilirubin were determined for preliminary establishment of pharmacological activity. Pathomorphological studies of rat liver were carried out using histological methods. The liver histological structure was inspected using liver sections stained with hematoxylin and eosin.Results and discussion. The component composition of WCHE is represented by oxycoumarins, hydroxycinnamic acids and flavonoids. The dominant phenolic compounds are esculetin, chicoriin, chicoric, chlorogenic and caftaric acids. It was found under acute experimental toxic hepatitis, that preliminary WCHE administration reduces the toxic TCM effect on liver cells. In animals treated with WCHE at doses both 100 mg/kg and 500 mg/kg body weight, it was observed decreases in ALT activity by 35 % and 45 %, AST by 15 % and 28 %, alkaline phosphatase by 15 % and 21 %; the content of total bilirubin by 20 % and 29 %, respectively, in comparison with similar indicators in the group of animals that were not treated with the extract. The histological study showed that WCHE administration to animals at the doses of 100 and 500 mg/kg reduces dystrophic changes in hepatocytes, this effect is more pronounced at the extract dosage of 500 mg/kg.Conclusion. Main WCHE components are oxycoumarins (esculetin, chicoriin), hydroxycinnamic acids (chicoric, chlorogenic and caftaric). According to the results of screening studies, it was established that WCHE in doses of 100 mg/kg and 500 mg/kg is a promising object for further pharmacological research.
- Open Access
- 29 August 2020
- Published by Center of Pharmaceutical Analytics Ltd in Drug development & registration
- Vol. 9 (3) , 143-149
Investigation of the Chemical Composition and Dopaminergic Activity of the Vitex Agnus-castus Fruits
Изучение химического состава и дофаминергической активности плодов Витекса священного ( Vitex agnus-castus L.)
- 29 August 2020
- Published by Center of Pharmaceutical Analytics Ltd in Drug development & registration
- Vol. 9 (3) , 143-149
Open AccessInvestigation of the Chemical Composition and Dopaminergic Activity of the Vitex Agnus-castus Fruits
Изучение химического состава и дофаминергической активности плодов Витекса священного ( Vitex agnus-castus L.)